Session ID: 
PM4

Steps Along the Trail to the Precision Medicine Summit

2:45pm - 3:45pm Monday, March 5
Las Vegas - Venetian Convention Center
Marcello 4405
Additional Registration
Extra Fee

Description

A panel of major precision medicine stakeholders share their perspectives on navigating the steps of precision medicine. The role of C&BI will be discussed by representatives of molecular diagnostic labs, health systems, pharma, and payers. Scientific knowledge and technological advances in genomics and genomics testing have increased exponentially, enabling molecular-based targeted therapies. Targeted therapies are shifting from research to clinical use cases. Analytics, data sharing networks and million-person cohorts are beginning to provide vast quantitative and qualitative data to advance precision medicine initiatives.
This session is part of a special program called Precision Medicine Symposium: Journey to the Summit Using Clinical and Business Intelligence. Extra fees and separate registration is required.

Learning Objectives: 

  • Identify the steps in implementing a precision medicine program
  • Describe the roles of the different precision medicine stakeholders including the patient perspective
  • Explain potential patient concerns with genetic testing and clinical decision making
  • Discuss the imperative of precision medicine and the need for analytics and data sharing to shift from standard care to targeted therapies
  • State the key elements to scale a precision medicine program to ensure a positive return on investment

Speaker(s): 

Executive Vice President and Chief Medical Officer,
Aetna
Senior Vice President, R&D, Medical and Chief Medical Officer,
Quest Diagnostics
Founder and President,
Syapse
Continuing Education Credits: 
ACHE
1.00
CAHIMS
1.00
CME
1.00
CNE
1.00
CPHIMS
1.00

Audience: 

C-Suite
Life Sciences Professionals
Physician, CMO, CMIO

Level: 

Intermediate

WHERE THE WORLD
CONNECTS FOR HEALTH